Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Sep 28, 2026
Nascent Biotech Market Cap
Nascent Biotech has a market cap or net worth of $34.57 thousand as of September 29, 2026. Its market cap has decreased by -97.14% in one year.
Market Cap
34.57K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since August 5, 2014, Nascent Biotech's market cap has decreased from 16.24M to 34.57K, a decrease of -99.79%. That is a compound annual growth rate of -39.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 34.57K | -66.67% |
| Dec 31, 2025 | 103.71K | -98.81% |
| Dec 31, 2024 | 8.74M | -69.97% |
| Dec 29, 2023 | 29.11M | 19.95% |
| Dec 30, 2022 | 24.27M | 341.66% |
| Dec 31, 2021 | 5.49M | 37.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProtoKinetix | 82.33K |
| Vincerx Pharma | 78.51K |
| PaxMedica | 63.14K |
| Scorpius Holdings | 61.14K |
| Panbela Therapeutics | 53.89K |
| Carisma Therapeutics | 33.48K |
| Entia Biosciences | 27.25K |
| Bio-Path Holdings | 25.15K |